Published in Ann Surg on January 01, 1980
Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes (2010) 2.07
Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg (2012) 2.00
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Influence of liver histopathology on transaminitis following total pancreatectomy and autologous islet transplantation. Dig Dis Sci (2012) 1.43
Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37
Pancreatic duct drainage in 100 patients with chronic pancreatitis. Ann Surg (1981) 1.31
Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med (1990) 1.23
One hundred pancreas transplants at a single institution. Ann Surg (1984) 1.20
Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud (2012) 0.99
Animal models of diabetes mellitus for islet transplantation. Exp Diabetes Res (2012) 0.96
Distal pancreatectomy and islet autotransplantation for chronic pancreatitis. Ann Surg (1981) 0.90
Islet transplantation for type 1 diabetes, 2015: what have we learned from alloislet and autoislet successes? Diabetes Care (2015) 0.88
Islet cell transplantation. Postgrad Med J (2007) 0.88
Human pancreatic cell autotransplantation following total pancreatectomy. Ann Surg (1981) 0.85
Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation. J Transplant (2011) 0.85
Encapsulated islets transplantation: Past, present and future. World J Gastrointest Pathophysiol (2012) 0.84
Islet autotransplantation and total pancreatectomy. Adv Surg (2014) 0.81
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes. World J Stem Cells (2014) 0.78
Recent experiences with autotransplantation of the kidney, jejunum, and pancreas. Ann Surg (1983) 0.77
Long-Term Glycemic Control in Adult Patients Undergoing Remote vs. Local Total Pancreatectomy With Islet Autotransplantation. Am J Gastroenterol (2017) 0.76
Combined laparoscopic spleen-preserving distal pancreatectomy and islet autotransplantation for benign pancreatic neoplasm. World J Gastroenterol (2014) 0.76
Spontaneous Hypoglycemia After Islet Transplantation: The Case For Using Non-Hepatic Sites. J Clin Endocrinol Metab (2016) 0.75
Islet autotransplantation in a patient with hypercoagulable disorder. World J Transplant (2016) 0.75
Hemodynamic measurements after administration of aprotinin and/or heparin during pancreatic cell autotransplantation in the dog, pig, and monkey. Ann Surg (1982) 0.75
Pancreatic islet autotransplantation with total pancreatectomy for chronic pancreatitis. Surg Today (2012) 0.75
Pancreatectomy for chronic pancreatitis. Ann Surg (1976) 2.44
Ninety-five per cent distal pancreatectomy for chronic pancreatitis. Ann Surg (1965) 1.64
Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg (1980) 1.58
Ketoacidosis in pancreatectomized man. N Engl J Med (1977) 1.38
Total pancreatectomy of end-stage chronic pancreatitis. Ann Surg (1978) 1.35
Identification of proinsulin and C-peptide in human serum by a specific immunoassay. Proc Natl Acad Sci U S A (1970) 1.33
Human islet autotransplantation following pancreatectomy. Transplant Proc (1979) 1.30
Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28
Successful intrasplenic autotransplantation of pancreatic tissue in totally pancreatectomised dogs. Transplantation (1976) 1.20
Surgical management of chronic relapsing pancreatitis. Am J Surg (1969) 1.13
A reappraisal of removal of ninety-five per cent of the distal portion of the pancreas. Surg Gynecol Obstet (1969) 1.12
Short-term culture of adult pancreatic fragments for purification and transplantation of islets of Langerhans. Surgery (1976) 1.07
Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine. Diabetes (1977) 0.99
Transplantation of dispersed pancreatic islet tissue in humans: autografts and allografts. Diabetes (1980) 0.99
Autotransplantation of pancreatic fragments to the portal vein and spleen of totally pancreatectomized dogs: a comparative evaluation. Ann Surg (1978) 0.98
Pancreatic islet autotransplantation: results in dogs with chronic duct ligation. Am J Surg (1980) 0.93
An improved amylase assay. J Dent Res (1969) 0.93
The operative treatment of pancreatitis. Arch Surg (1969) 0.91
Islet transplantation. Surg Gynecol Obstet (1977) 0.90
Autotransplantation of pancreatic islets without separation of exocrine and endocrine tissue in totally pancreatectomized dogs. Surgery (1977) 0.90
Fatal outcome from emergency embolization of an intrahepatic aneurysm: a case report. Surgery (1980) 0.87
LIFE WITHOUT A PANCREAS. Lancet (1965) 0.87
Infant human pancreas. A potential source of islet tissue for transplantation. Diabetes (1976) 0.86
Surgical treatment of chronic pancreatitis. A review after a ten-year experience. Arch Surg (1980) 0.85
A SIMPLE IMMUNOASSAY FOR INSULIN: APPLICATION TO HUMAN AND DOG PLASMA. J Clin Endocrinol Metab (1963) 0.85
Pancreatic autotransplantation following resection. Surgery (1978) 0.85
Total pancreatectomy for chronic relapsing pancreatitis and calcinosis of the pancreas. U S Armed Forces Med J (1957) 0.84
Clinical and metabolic response to radical distal pancreatectomy for chronic pancreatitis. Am J Surg (1967) 0.83
FATAL DIABETIC GLOMERULOSCLEROSIS AFTER TOTAL PANCREATECTOMY. N Engl J Med (1964) 0.83
[Autotransplantion of Langerhans islets after total duodeno-pancreatectomy in a patient with chronic pancreatitis (author's transl)]. Dtsch Med Wochenschr (1978) 0.79
Subtotal pancreatectomy for chronic pancreatitis. Am J Surg (1969) 0.79
Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol (1999) 7.65
Functional organization of the nuclear envelope. Annu Rev Cell Biol (1988) 5.80
A monoclonal antibody against a 135-K Golgi membrane protein. EMBO J (1982) 4.89
Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78
Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med (1989) 4.40
Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30
A cell free system to study reassembly of the nuclear envelope at the end of mitosis. Cell (1986) 3.90
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
Viral membrane proteins acquire galactose in trans Golgi cisternae during intracellular transport. J Cell Biol (1982) 3.18
Teratocarcinoma stem cells and early mouse embryos contain only a single major lamin polypeptide closely resembling lamin B. Cell (1987) 2.88
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Interactions and three-dimensional localization of a group of nuclear pore complex proteins. J Cell Biol (1994) 2.63
Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery (1967) 2.49
Transplantation of stomach, intestine, and pancreas: experimental and clinical observations. Surgery (1967) 2.49
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
Sequential recruitment of NPC proteins to the nuclear periphery at the end of mitosis. J Cell Sci (1999) 2.42
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Targeting and function in mRNA export of nuclear pore complex protein Nup153. J Cell Biol (1996) 2.38
Nup153 is an M9-containing mobile nucleoporin with a novel Ran-binding domain. EMBO J (1999) 2.37
Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med (1990) 2.32
Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. J Cell Sci (2001) 2.28
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11
Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol (1997) 2.09
Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04
Expression of Semliki Forest virus proteins from cloned complementary DNA. I. The fusion activity of the spike glycoprotein. J Cell Biol (1983) 2.03
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol (1974) 1.86
Cytoskeleton-membrane interactions. Curr Opin Cell Biol (1996) 1.83
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83
Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest (1985) 1.80
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg (1997) 1.79
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg (1996) 1.75
Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes (1975) 1.74
Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med (1992) 1.74
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood (1988) 1.72
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Expression of Semliki Forest virus proteins from cloned complementary DNA. II. The membrane-spanning glycoprotein E2 is transported to the cell surface without its normal cytoplasmic domain. J Cell Biol (1983) 1.70
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet (1993) 1.70
Internuclear exchange of an inner nuclear membrane protein (p55) in heterokaryons: in vivo evidence for the interaction of p55 with the nuclear lamina. J Cell Biol (1990) 1.70
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Hepatic resection for secondary neoplasms. Surgery (1982) 1.64
Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. J Clin Microbiol (1999) 1.62
Identification of a 200-kD, brefeldin-sensitive protein on Golgi membranes. J Cell Biol (1992) 1.61
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation (1994) 1.58
Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity. Clin Exp Immunol (1974) 1.55
Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc Natl Acad Sci U S A (1994) 1.55
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med (1990) 1.53
The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53
Newly synthesized G protein of vesicular stomatitis virus is not transported to the cell surface during mitosis. J Cell Biol (1983) 1.53
Pancreatitis and hyperparathyroidism. Br J Surg (1988) 1.52
Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes. Infect Immun (1980) 1.52
Improved islet isolation from rat pancreas using 35% bovine serum albumin in combination with Dextran gradient separation. Transplantation (1996) 1.51
Inhibition of N-linked oligosaccharide trimming does not interfere with surface expression of certain integral membrane proteins. EMBO J (1984) 1.51
Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes (1992) 1.51
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation (1989) 1.46
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45